The in vitro results demonstrated that tumor cells then could specifically take up these exfoliated fragments due to the tumor-targeting specificity of FA and elicit ICD by the MTO, resulting in DNA-associated TAA release. The gene discussed is SELENBP1; the disease is neoplasm.